Making optimal use of combination pharmacotherapy in bipolar disorder

Journal of Clinical Psychiatry

Volumn 65, Issue SUPPL. 15, 2004, Pages 21-24

  Bowden, Charles L ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT;

BIPOLAR DISORDER; DRUG COMBINATION; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; PSYCHIATRY; REVIEW; UNITED STATES;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; HUMANS; PRACTICE GUIDELINES; PSYCHIATRY; SOCIETIES, MEDICAL; UNITED STATES;

EID: 16544386332     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Tohen M, Chengappa KN, Suppes T, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002;59:62-69
2. Sachs GS, Grossman F, Ghaemi SN, et al. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002;159:1146-1154
3. Bowden CL. Combination therapy vs monotherapy for the treatment of bipolar disorder. Presented at the Bipolar Care OPTIONS South Central Regional Working Group; July 25-26, 2003; Dallas, Tex
4. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Bipolar Disorder [revision]. Am J Psychiatry 2002;159 (suppl 4):1-50
5. Suppes T, Leverich GS, Keck PE, et al. The Stanley Foundation Bipolar Treatment Outcome Network, 2: demographics and illness characteristics of the first 261 patients. J Affect Disord 2001;67:45-59
6. Muller-Oerlinghausen B, Retzow A, Henn FA, et al, for the European Valproate Mania Study Group. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. J Clin Psychopharmacol 2000;20:195-203
7. Spina E, Perucca E. Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. Epilepsia 2002;43:37-44
8. Licht RW, Olesen OV, Friis P, et al. Olanzapine serum concentrations lowered by concomitant treatment with carbamazepine. J Clin Psychopharmacol 2000;20:110-112
9. Young LT, Joffe RT, Robb JC, et al. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000;157:124-126
10. Nemeroff CB, Evans DL, Gyulai L, et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001;158:906-912
11. Vieta E, Martinez-Arán A, Goikolea JM, et al. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry 2002; 63:508-512
12. Bowden CL. Lamotrigine in the treatment of bipolar disorder. Expert Opin Pharmacother 2002;3:1513-1519
13. DelBello MP, Schwiers ML, Rosenberg HL, et al. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002;41:1216-1223
14. Mullen J, Devine N, Sweitzer D. Quetiapine adjunctive therapy for acute mania associated with bipolar disorder (SIAM). In: New Research Abstracts of the 156th Annual Meeting of the American Psychiatric Association; May 20, 2003; San Francisco, Calif. Abstract NR482: 180-181
15. Suppes T, Webb A, Paul B, et al. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 1999;156:1164-1169
16. El-Mallakh RS, Karippot A. Use of antidepressants to treat depression in bipolar disorder. Psychiatr Serv 2002;53:580-584
17. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987;144: 1403-1411
18. Kukopulos A, Reginaldi D, Laddomada P, et al. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol 1980;13:156-167
19. Sachs GS, Grossman F, Ghaemi SN, et al. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002;159:1146-1154